Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study.

about

Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: a prospective, pilot study.Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.

P2860

Q39467333-34F5D71A-5A34-4163-8728-69698D916608 Q47704193-FFE3C57E-DE4A-4F5A-9092-FF735DADC713

P2860

Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study.

Item

http://www.wikidata.org/entity/Q38466939

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effect of Discontinuation of T ...... ctive, Randomized Pilot Study.

@en

type

Item

label

Effect of Discontinuation of T ...... ctive, Randomized Pilot Study.

@en

prefLabel

Effect of Discontinuation of T ...... ctive, Randomized Pilot Study.

@en

P1476

Effect of Discontinuation of T ...... ctive, Randomized Pilot Study.

@en

P2093

Dong Hyuk Kang

http://www.w3.org/2001/XMLSchema#string

Hong Yong Choi

http://www.w3.org/2001/XMLSchema#string

Joo Yong Lee

http://www.w3.org/2001/XMLSchema#string

Seung Wook Lee

http://www.w3.org/2001/XMLSchema#string

Sung Yul Park

http://www.w3.org/2001/XMLSchema#string

Yong Tae Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasteride.

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.

Medication adherence: WHO cares?

The role of combination medical therapy in benign prostatic hyperplasia.

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

Impact of medical treatments for benign prostatic hyperplasia on sexual function.

Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.

Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.

Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

P304

35-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1757-5672.2011.00109.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hong Sang Moon

P577

2011-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26676457

http://www.w3.org/2001/XMLSchema#string

Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study.

about

P2860

P2860

Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698